Oct 13, 2015 at 20:38 | Source: PTI
The voluntary Class III ongoing recall for the extended-release tablets has been initiated as "one lot of product did not meet the first stage dissolution specification limits", USFDA said in the Enforcement Report for the week of October 7, 2015.
Dec 03, 2014 at 13:24 | Source:
Meda Pharmaceuticals Inc. and Cipla sued Apotex Inc. and Apotex Corp. in Federal District Court in Delaware to enforce the Orange-Book listed patents covering Dymista Nasal Spray in response to Apotex's submission to the USFDA of an ANDA.
Nov 07, 2014 at 10:04 | Source:
Brokerages are worried about the stocks and stress that approval of Sun Pharma-Ranbaxy deal will be key driver. They feel that this negative surprise may benefit Dr Reddy's.
Oct 01, 2014 at 16:56 | Source: PTI
The Canadian regulator said IPCA has not disputed the FDA findings with Health Canada even as the FDA has not issued a recall of any of the affected products.
Sep 26, 2014 at 21:28 | Source: CNBC-TV18
The USFDA has served import alerts to Canadian drug company Apotex Researchs manufacturing facility in Bangalore and Indian firm Micro Labs manufacturing unit in Goa. For both the drug companies, this is their second Indian facility being banned by USFDA.
Apr 03, 2014 at 14:46 | Source: Reuters
Drugs made at the plant, based in Bangalore, will be detained without physical examination because the factory did not meet the FDA's good manufacturing practices, the agency said on its website on Wednesday.
May 21, 2010 at 13:19 | Source: Reuters
Ranbaxy Laboratories, India's largest drugmaker by sales, has launched a generic version of Pfizer's cholesterol-lowering drug Lipitor in Canada, the company said on Friday.
May 20, 2010 at 15:24 | Source: Reuters
Generic forms of Pfizer Inc's blockbuster Lipitor cholesterol fighter began flooding into Canada on Wednesday, in a taste of what is to come for the USD 12 billion-a-year drug next year in the United States
Feb 06, 2009 at 16:18
Apotex Inc. of Canada and Intas Biopharmaceuticals Limited of India have extended their business agreement to develop a biosimilar version of pegfilgrastim, a protein that is used to treat neutropenia (a side effect of cancer chemotherapy).
May 05, 2008 at 15:36
Intas plans Filgrastim launch in North America, Europe. IBPL and Apotex are keen to explore prospective business opportunities for more biosimilar products in the coming years.

Photos »

Apotex recalls hypertension drug made by Indian arm
Meda and Cipla sue Apotex to enforce Dymista patents
Ranbaxy, Sun Pharma fall 4-5%; analysts say DRL to benefit
Health Canada issues import ban on Apotex India, IPCA
USFDA bans two Indian plants on GMP violations
FDA bans imports from Canadian Apotex's India plant
Ranbaxy launches Lipitor generic in Canada
Lipitor generics reach Canada, Pfizer vows fight
IBPL- Apotex to develop biosimilar version of pegfilgrastim
Messages on Apotex »


Gold Member


Ranbaxy Labs  

FDA bans imports from India plant of Canada’s Apotex

12.03 PM Apr 4th 2014


Platinum Member


Aurobindo Pharm  

last year auro at 1st position in securing highest no.of approval compared to indian pharma companies n at 3rd position globally after mylan n apotex. In 2013, till june end data, auro n sun both at 1st position with 15 approval, compared amongst all indian pharma companies. Gud for auro. Anybody

6.25 PM Jul 22nd 2013


New Member

0 Follower

Aurobindo Pharm  

, Apotex Corp, Breckenridge Pharmaceutical Inc, Glenmark Generics , Hetero USA Inc Mylan Pharmaceuticals Inc. Petitions were also filed against Ranbaxy Laboratories, Sandoz Inc, ScieGen Pharmaceuticals Inc, Sun Pharma, Watson Laboratories Inc and Zydus Pharmaceuticals

4.01 PM Jul 22nd 2013


Platinum Member


Sun Pharma  

Generics Approval Rizatriptan Benzoate rizatriptan benzoate Tablet, Orally Disintegrating; Oral Apotex Inc Approval Rizatriptan Benzoate rizatriptan benzoate Tablet; Orally Disintegrating Aurobindo Pharma Ltd Approval Rizatriptan Benzoate rizatriptan benzoate Tablet; Orally Disintegrating Natco Pharma Ltd

8.42 PM Jul 7th 2013

MMB Moderator

Platinum Member


Sun Pharma  

had also announced earlier this week that its US generics arm received FDA approval for Riluzole in 50 mg strength, indicated for the treatment of amyotrophic lateral sclerosis. Riluzole had sales of USD 64 million for the year ended March 2013, Glenmark had said. Apotex Corp and Impax Labs

12.26 PM Jun 22nd 2013


Platinum Member


Sun Pharma  

for Riluzole in 50 mg strength, indicated for the treatment of amyotrophic lateral sclerosis. Riluzole had sales of USD 64 million for the year ended March 2013, Glenmark had said. Apotex Corp and Impax Labs are the two other firms, that have also got US FDA approval to sell the drug. Sun Pharma shares were

8.33 PM Jun 21st 2013

Web Messenger

Platinum Member


Other Market Topics  

USA, and the Generic olanzapine orally disintegrating tablets will be manufactured by Apotex, DRL an

7.52 PM Oct 25th 2011


Platinum Member



Pharmaceuticals, USA, Inc, Apotex Corp, and Apotex Inc in the United States District Court for the Eastern District of Virginia for infringement of the reissue patent," Pfizer said in a statement on its website. Each of these generic companies previously filed an abbreviated new drug application with the United

3.31 AM Mar 9th 2013


Gold Member


Alembic Pharma  

, Aurobindo Pharma, Dr Reddy`s Laboratories, Lupin, Macleods Pharmaceuticals filed more than 8 DMFs. Further, Hetero Labs, Unimark Remedies, Neuland Laboratories, MSN Laboratories, Alembic Pharmaceuticals, Apotex Pharmachem India Pvt Ltd and CTX Life Sciences Pvt Ltd filed 5-7 DMFs during the first nine

12.03 AM Nov 2nd 2012


Gold Member


Torrent Pharma  

received the US FDA`s approval for the first generic versions of Merck`s Singulair (montelukast sodium). Besides these firms, global generic firms like Apotex Inc, Endo Pharmaceuticals, Kudco Ireland, Mylan, Roxane Laboratories, Sandoz, and Teva Pharmaceuticals have also got the nod. While Apotex

3.42 AM Aug 11th 2012

News across the web »
Oct 09, 2014 at 18:42 | Source: Calcutta Telegraph News
Apr 03, 2014 at 14:00 | Source: NDTV Profit
Explore Moneycontrol

Copyright © Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of is prohibited.